ArticleAntimicrobial agents and chemotherapy2005

Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.

Katsunori Takashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.